What’s Going On With CrowdStrike Stock Thursday?

CrowdStrike Holdings Inc (NASDAQ: CRWD) shares are trading higher Thursday after multiple analysts raised price targets on the stock.

CrowdStrike Holdings Inc (NASDAQ:CRWD) shares are trading higher Thursday after multiple analysts raised price targets on the stock.

  • Barclays analyst Saket Kalia maintained CrowdStrike with an Overweight and raised the price target from $186 to $200.
  • Needham analyst Alex Henderson maintained CrowdStrike with a Buy and raised the price target from $200 to $215.
  • Rosenblatt analyst Catharine Trebnick maintained CrowdStrike with a Buy and raised the price target from $190 to $200.

The price target increases come after CrowdStrike made several announcements at Fal.Con 2023 this week including a new partner program called Accelerate, CrowdStrike Marketplace, the next generation of Falcon with generative AI capabilities, new innovations for data protection and exposure management and a no-code application development platform. 

CrowdStrike also announced that it has agreed to acquire Bionic, which focuses on application security posture management.

“We are delivering what customers need: modern protection to address cloud security risk comprehensively, through one unified platform,” said George Kurtz, co-founder and CEO of CrowdStrike.

CRWD Price Action: CrowdStrike shares were up 2.03% at $167.48 at the time of publication, according to Benzinga Pro.

Photo: methodshop from Pixabay.

Total
0
Shares
Related Posts
Read More

Asia Markets Mixed, Europe Up, Crude Oil Trades At $77 – Global Markets Today While US Was Sleeping

On Friday, November 11th U.S. stock markets closed higher, spurred by tech giants amid easing Treasury yields, with investor focus on next week's inflation and economic updates. In economic data, the University of Michigan's consumer sentiment fell to a six-month low of 60.4 in November from 63.8 in October, below market expectations of 63.7.

ADIV

Read More

Organic Growth And Innovation Drive YoY Increase In Cannabis Producer Organigram’s Q4 Revenue And Adjusted EBITDA

Canadian cannabis producer Organigram Holdings reported an 11% year-over-year increase in net revenue for the fourth quarter, reaching C$A161.6 million ($121 million). The company credited the growth to its focus on innovative products that meet consumer demand for convenience, such as pre-rolls and edibles. The increase in revenue contributed to a 71% rise in adjusted EBITDA to nearly CA$6m for the quarter, compared with the same period in 2022. Organigram's adjusted gross margin was CA$40.2m, up 20% on 2022. The company also reported a net loss of CA$248.6m, compared with CA$14.3m in 2022, due to impairments on property, plant and equipment, intangibles and goodwill. Organigram said it expects improved margins in future as efficiency gains from facility upgrades and expansion into higher-margin categories such as craft flower and vapes bear fruit.

OGI